Amber Cai
InvestorVenture Partner at F-Prime Capital Partners
About
Amber Cai is a Venture Partner at F-Prime, working on early-stage biotechnology investments. She is the founding CEO of Skyline Therapeutics, a gene and cell therapy company, and was previously a founding member of Novartis' R&D Center in China, later serving as its Head of Operations after helping establish the center from 2005-2006; earlier she worked in business development at Novartis Institutes for BioMedical Research in Cambridge, MA. She holds a PhD from MIT in GPCR signaling and an MBA from MIT Sloan School of Management.
Invests in
Biotech
Colleagues at F-Prime Capital Partners
Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Alexander Pasteur
Partner at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners
Bala Varadhan
Principal at F-Prime Capital Partners